Jun 9, 2023 3:43 PM
BACK TO TOP
KSE100
41,880.08
193.62
(0.46%)
ALLSHR
28,192.07
67.63
(0.24%)
KSE30
14,805.86
63.50
(0.43%)
KMI30
72,282.19
352.00
(0.49%)
BKTI
9,043.39
-0.87
(-0.01%)
OGTI
10,741.28
11.35
(0.11%)
KMIALLSHR
20,627.19
55.73
(0.27%)
PSXDIV20
14,659.10
83.30
(0.57%)
UPP9
12,060.08
40.54
(0.34%)
NITPGI
9,647.37
42.86
(0.45%)
NBPPGI
11,201.13
52.53
(0.47%)
MZNPI
8,875.26
82.32
(0.94%)
JSMFI
9,214.82
30.91
(0.34%)
ACI
7,220.65
100.59
(1.41%)
HBLTTI
11,400.65
07-06-2023
5.33
(0.05%)
GlaxoSmithKline Consumer Healthcare
PHARMACEUTICALS
Rs.120.23
-3.88
(-3.13%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Mon, Jan 30, 2023 3:33 PM
REG
FUT
ODL
Open
124.21
High
124.25
Low
120.00
Volume
8,500
CIRCUIT BREAKER
114.80 — 133.42
DAY RANGE
120.00 — 124.25
52-WEEK RANGE
120.00 — 243.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
124.11
VAR
18.50
HAIRCUT
22.50
P/E Ratio (TTM) **
33.21
1-Year Change *
-47.77%
YTD Change *
-26.64%

No record found

Open
126.01
High
126.01
Low
124.00
Close
124.00
Change
-3.56%
LDCP
0.00
Volume
80
Total Trades
5
CIRCUIT BREAKER
111.70 — 136.52
DAY RANGE
124.00 — 126.01
Ask Price
133.00
Ask Volume
22
Bid Price
120.10
Bid Volume
22
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on March 31, 2015 principally to effect the demerger of consumer healthcare business of GlaxoSmithKline Pakistan Limited (GSK Pakistan). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is Haleon plc. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.

KEY PEOPLE
Mr. Farhan Muhammad HaroonCEO
Mr. M.Z. Moin MohajirChairman
Ms. Mashal MohammadCompany Secretary
ADDRESS

Sandoz Nagar, Petaro Road, Jamshoro, Sindh.

WEBSITE

www.pk-consumerhealthcare.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.

AUDITOR

Yousuf Adil, Chartered Accountants

Equity Profile

Market Cap (000's)
14,073,463.50
Shares
117,054,508
Free Float
15,615,515
Free Float
13.34%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 27, 2022Transmission of Quarterly Report for the Period Ended 30 September 2022 View   PDF
Oct 21, 2022Financial Results for the Quarter Ended 30 September 2022 View   PDF
Aug 29, 2022 Transmission of Half Yearly Report for the Period Ended 30 June 2022 View   PDF
Aug 23, 2022Financial Results for the Quarter Ended 30 June 2022 View   PDF
Apr 27, 2022Transmission of Quarterly Report for the Period Ended 31 March 2022 View   PDF
Apr 25, 2022Financial Results for the Quarter Ended 31 March 2022 View   PDF
Feb 28, 2022Transmission of the Annual Report for the Year Ended 2021 View   PDF
Feb 9, 2022Financial Results for the Year Ended 31 December 2021 View   PDF
Oct 29, 2021Transmission of Quarterly Report for the Period Ended 30 September 2021 View   PDF
Oct 26, 2021Financial Results for the Quarter Ended 30 September 2021 View   PDF
DateTitleDocument
Dec 5, 2022Results of the Board of Directors Meeting Other than Financial Results View   PDF
Dec 5, 2022CTC of Special Resolutions Passed in the Extraordinary General Meeting 2022 View   PDF
Nov 25, 2022Notice of Board Meeting Other Than Financial Results View   PDF
Nov 14, 2022Notice of Extraordinary General Meeting - 2022 View   PDF
Nov 11, 2022Prior Publication of Extraordinary General Meeting Notice - 2022 View   PDF
Oct 13, 2022Notice of Board of Directors Meeting - (Q3-2022) View   PDF
Aug 15, 2022Notice of Board of Directors Meeting - (Q2-2022) View   PDF
Apr 22, 2022Board Meeting in Progress View   PDF
Apr 14, 2022Notice of Board of Directors Meeting - (Q1-2022) View   PDF
Mar 21, 2022CTC of Resolutions Passed in the Annual General Meeting 2021 View   PDF
DateTitleDocument
Jan 6, 2023Approval of Company Name Change - Haleon Pakistan Limited View   PDF
Nov 10, 2022Material Information - Appointment of Non-Executive Director View   PDF
Nov 4, 2022Lifting of Force Majeure - Panadol Tablets, Panadol Extra Tablets and Children s Panadol Liquid Range View   PDF
Nov 2, 2022Notice of Corporate Briefing Session 2022 - Revised Date View   PDF
Oct 27, 2022Notice of Corporate Briefing Session - 2022 View   PDF
Oct 21, 2022Force Majeure - Panadol Tablets, Panadol Extra Tablets and Children s Panadol Liquid Range View   PDF
Sep 16, 2022Panadol - Material Information View   PDF
Aug 24, 2022Notice of Update in Email Address for Shareholders View   PDF
Aug 23, 2022BoD Approval of Change of Company Name View   PDF
Jul 29, 2022Demerger of Haleon plc and Change in Ultimate Parent of the Company View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales24,163,15019,846,10616,316,74514,875,268
Profit after Taxation2,134,3341,262,0091,257,5191,074,553
EPS18.2310.7810.749.18
Q3 2022Q2 2022Q1 2022Q3 2021
Sales6,593,6147,087,1037,127,1516,079,605
Profit after Taxation(345,213)(279,313)556,599363,894
EPS(2.95)(2.39)4.763.11
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)27.3826.8530.5629.18
Net Profit Margin (%)8.836.367.717.22
EPS Growth (%)69.110.3716.9924.22
PEG0.1966.041.401.20

Payouts

DateFinancial ResultsDetailsBook Closure
March 5, 2021 5:21 PM31/12/2020(YR) 50%(F) (D) 17/04/2021 - 21/04/2021
March 12, 2020 6:23 PM31/12/2019(YR) 50%(F) (D) 14/05/2020 - 20/05/2020
March 18, 2019 5:17 PM31/12/2018(YR) 50%(F) (D) 18/04/2019 - 23/04/2019
January 29, 2018 3:23 PM31/12/2017(YR) 50% (D) 23/03/2018 - 29/03/2018

Financial Reports